DERM PDUFA decision: a positive outcome, +7.3%

On November 1, 2024, Journey Medical Corporation reached its PDUFA decision. The result was a positive outcome, and the stock moved +7.3% in the window around the event. It had already run -8.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.